We compared our optimal PTX nanovesicle to these two PTX nanoparticles and found that CD47p/AZE–paclitaxome significantly outperformed CP–PTX and PGG–PTX in PK, tumor uptake and penetration, and efficacy in a pancreatic cancer (PC) mouse model. Here, CP is linked to neoplasm.